|
May 20
|
Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
|
|
Apr 7
|
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
|
|
Apr 7
|
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
|
|
Mar 14
|
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
|
|
Mar 12
|
Life Sciences Investor Forum Agenda Announced for March 13th
|
|
Jun 21
|
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
|
|
Jun 19
|
Avicanna General Meeting
|
|
Jun 19
|
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
|
|
Jun 18
|
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
|
|
Jun 18
|
Avicanna to Present at the Life Science Investor Forum June 20th, 2024
|
|
Dec 4
|
Avicanna Announces Closing of Non-Brokered Private Placement
|
|
Jul 17
|
Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay
|